Phase 1 Trial



Phase 1 Trial Recent News

Sanofi's Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine
AbbVie - Genmab Post Epcoritamab Data From Early-Stage Blood Cancer Study
Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial
Repare Therapeutics Shares Dip After Updated RP-3500 Data In Solid Tumors
FDA Approves BioCardia's Phase 1 Trial With Cell Therapy In COVID-19, Shares Jump
IO Biotech Reveals Updated Data From IO102-IO103/Opdivo Combo Trial In Melanoma
BioNTech Posts Interim Phase 1 Data From CAR-T/Cancer Vaccine Combo In Solid Tumors
AIM ImmunoTech Shares Jump On Positive Data From Ampligen Study In Breast Cancer Setting
Zentalis Pharma Posts Initial Clinical Data On Its Wee1 Inhibitor In Ovarian Cancer
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
Seres Therapeutics Ditches Its SER-301 Phase 1b Second Study In Ulcerative Colitis
VBI Vaccines To Start Clinical Study Of Pan-Coronavirus Vaccine Candidate This Year
Stealth Bio's SBT-272 Shows Encouraging Action In Huntington's Disease Animal Model
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
CureVac - GSK Start Dosing In Next-Gen COVID-19 Vaccine Candidate Trial
Synthetic Biologics' VCN-01 Shows Favorable Safety Profile, Clinical Activity In Early-Stage Cancer Study
Ionis-Biogen Partnered Amyotrophic Lateral Sclerosis Trial Disappoints
Pluristem's PLX-R18 Shows Meaningful Advantage Over Other Treatments In Transplant Patients
Aligos Pulls Plug On Early-Stage Chronic Hepatitis B Treatment Candidate
Why ORIC Pharmaceuticals Shares Are Plunging Today
Terns Reports Topline Results from Early-Stage NASH Study
Pulmatrix's COPD Candidate Shows Early Safety, Preliminary Pharmacokinetic Results